BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34224813)

  • 41. Hexane fraction of Annona muricata (Sour sop) seed ameliorates testosterone-induced benign prostatic hyperplasia in rats.
    Adaramoye OA; Oladipo TD; Akanni OO; Abiola OJ
    Biomed Pharmacother; 2019 Mar; 111():403-413. PubMed ID: 30594779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effects of finasteride and laser-irradiated silver nanoparticles on testicular function and histology in testosterone induced benign prostatic hyperplasia in rats.
    Marghani BH; Ezz MA; Ateya AI; Fehaid A; Saleh RM; Rezk S
    Life Sci; 2023 Jul; 324():121747. PubMed ID: 37137466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
    Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
    Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.
    Na Y; Ye Z; Zhang S
    Clin Drug Investig; 2012 Jan; 32(1):29-39. PubMed ID: 27933597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Roehrborn CG; Manyak MJ; Palacios-Moreno JM; Wilson TH; Roos EPM; Santos JC; Karanastasis D; Plastino J; Giuliano F; Rosen RC
    BJU Int; 2018 Apr; 121(4):647-658. PubMed ID: 29044968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
    Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
    J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
    Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of
    Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
    [No Abstract]   [Full Text] [Related]  

  • 50. Combination of Lycopene and Curcumin Synergistically Alleviates Testosterone-Propionate-Induced Benign Prostatic Hyperplasia in Sprague Dawley Rats via Modulating Inflammation and Proliferation.
    Wang S; He W; Li W; Zhou JR; Du Z
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
    Xue Z; Lin Y; Jiang Y; Wei N; Bi J
    BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of Xialiqi Capsules on the expressions of PCNA and caspase-3 in rats withbenign prostatic hyperplasia].
    Cai HC; Song LB; Zhang GW; Qing XR; Mo DS; Liu W; Zhan XX; Huang YF; Shang XJ
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):728-733. PubMed ID: 29726649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effects of
    Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
    Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
    [No Abstract]   [Full Text] [Related]  

  • 54. Protective effects of
    Onoja RI; Olumuyiwa Shoyinka SV; Omeke JN; Emejuo NT; Ugwoke SN
    Vet Res Forum; 2023; 14(2):59-64. PubMed ID: 36909686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
    Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
    J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect Of Continuously Dutasteride Monotherapy on The Expression Of Protein Kinase C-Alpha Enzyme In BPH Model Of Wistar Strain Rattus Novergicus Rat.
    Daryanto B; Suharibawa IGLA; Purnomo AF; Nurhadi P; Wardhani V
    Med Arch; 2023; 77(3):202-206. PubMed ID: 37700916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
    Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
    Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.
    Mizoguchi S; Mori K; Shin T; Wang Z; DeFranco DB; Yoshimura N; Mimata H
    Prostate; 2020 Dec; 80(16):1413-1420. PubMed ID: 32941694
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    N Ogbu P; U S Ezeanyika L; Ogugua VNE; M Ogbu I; Aloke C; N Ony G
    Pak J Biol Sci; 2021 Jan; 24(1):151-157. PubMed ID: 33683042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.